<DOC>
	<DOCNO>NCT00545207</DOCNO>
	<brief_summary>This 2 arm study compare effect oral Bonviva ( 150mg , monthly ) placebo parameter bone micro-architecture , assess CT scan , bone turnover bone mineral density . Patients randomize receive either Bonviva 150mg po placebo monthly , measurement take baseline , interval 2 year . The anticipated time study treatment 2+ year , target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study Bonviva ( Ibandronate ) Once Monthly Post-Menopausal Women With Osteopenia .</brief_title>
	<detailed_description />
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<criteria>postmenopausal woman , age 5575 year ; diagnose osteopenia . history osteoporotic vertebral fracture ; contraindication ibandronate .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>